COHANCE stock
COHANCE is showing a constructive news setup around Chemicals, with 1 recent story and improving sentiment breadth.
COHANCE has built a constructive coverage cluster in the last 1 day. The strongest recurring theme is Chemicals, while the current weighted impact score is +62 from 1 bullish, 0 bearish, and 0 neutral stories across 1 sources.
COHANCE is last saved at ₹443.15 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
This is the first public financial report for COHANCE. The company reported revenues of Rs 307.15 crore and a profit of Rs 83.29 crore. This filing provides the initial financial snapshot of the company's performance. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 27 days ago · 2 min read
Economic Times · 9 Jul 2026 · 2 min read
Economic Times · 13 May 2026 · 2 min read
Economic Times · 2 May 2026 · 2 min read
Economic Times · 29 Apr 2026 · 2 min read
How COHANCE stacks against related names in this news cluster
COHANCE has appeared across 1 recent stories from 1 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
COHANCE coverage is currently leaning bullish, with 1 bullish, 0 bearish, and 0 neutral analyzed stories in the recent window.
Recent COHANCE coverage is clustering around Chemicals and Pharmaceuticals. Related names showing up alongside COHANCE include FACT, JPPOWER, KAYNES.
Use this page as a coverage hub for COHANCE: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
1 recent mentions linked to COHANCE
TopicPharmaceuticals1 recent mentions linked to COHANCE
StockFACTRelated news cluster with 1 links
Latest storyBullish read: MANKIND, COHANCE, KAYNES RSI Trending Up; WatchThe pharma sector has recently outshined PSU and energy stocks (Context [6]), suggesting a favorable
How retail crowds and channels are talking about COHANCE right now — context for your own research, not a trade call.